Levothyroxine Sodium
- Product NDC
- 68071-3692
- 11-digit product format
- 680713692
- Labeler code
- 68071
- Product ID
- 68071-3692_23808d9e-74ef-0104-e063-6394a90a1fae
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Levothyroxine Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCarePharmaceuticals, Inc.
- Application
- ANDA209713
- Marketing category
- ANDA
- Marketing start
- 2019-03-20
- Substance
- LEVOTHYROXINE SODIUM
- Active strength
- .125 mg/1
- Pharmacologic classes
- Thyroxine [CS], l-Thyroxine [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Levothyroxine Sodium
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LEVOTHYROXINE SODIUM | .125 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 9J765S329G |
| Rxcui | 966224 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68071-3692-9 | Levothyroxine Sodium | 90 in 1 BOTTLE | TABLET | 90 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68071-3692 | LEVOTHYROXINE SODIUM TABLET [NUCAREPHARMACEUTICALS, INC.] | 1 | Current NDC, 1 package rows | 20241004_2380859a-5b65-f88f-e063-6394a90aa4e2.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 68071-3692-9 | 68071369209 | 90 TABLET in 1 BOTTLE (68071-3692-9) | 90 tablet | 2024-10-02 | No | No | Current |